06-15-2009, 11:59 AM
(The ACCORD trial was designed to determine if a strategy of intensive lowering of blood sugar levels, intensive lowering of blood pressure, or treatment of blood lipids with a fibrate plus a statin, can reduce the risk of major CVD events in patients with type 2 diabetes who are at especially high risk of CVD.)
result: lowest mortality rates occured when HbA1c levels were controlled to be in this range:
1. >8
2. 7-7.9 (standard arm of Rx)
3.
result: lowest mortality rates occured when HbA1c levels were controlled to be in this range:
1. >8
2. 7-7.9 (standard arm of Rx)
3.